JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$1.09B |
| 2 |
Broadcom
AVGO
|
+$1.03B |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$970M |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$877M |
| 5 |
Verizon
VZ
|
+$875M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.37B |
| 3 |
TWX
Time Warner Inc
TWX
|
+$764M |
| 4 |
IBM
IBM
|
+$737M |
| 5 |
Philip Morris
PM
|
+$640M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Financials | 14% |
| 3 | Technology | 12.71% |
| 4 | Healthcare | 9.7% |
| 5 | Consumer Discretionary | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
GWR
2626
DELISTED
Genesee & Wyoming Inc.
GWR
| $4.64M | ﹤0.01% |
57,108
-146
| -0.3% | -$11.1K |
2013 Q2
20 quarters
|
|
|
BPMC
2627
DELISTED
Blueprint Medicines
BPMC
| $4.64M | ﹤0.01% |
73,107
+20,349
| +39% | +$1.62M |
2015 Q2
12 quarters
|
|
2628
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.4B
| $4.64M | ﹤0.01% |
55,542
-40,791
| -42% | -$3.41M |
2013 Q2
20 quarters
|
|
|
BNY
2629
CALL
Bank of New York Mellon
BNY
$98.7B
| $4.64M | ﹤0.01% |
86,000
| – | – |
2017 Q3
3 quarters
|
|
2630
MongoDB
MDB
$28.8B
| $4.63M | ﹤0.01% |
93,333
+24,980
| +37% | +$1.12M |
2017 Q4
2 quarters
|
|
2631
Americold
COLD
$3.97B
| $4.63M | ﹤0.01% |
210,023
-328,574
| -61% | -$6.88M |
2018 Q1
1 quarter
|
|
|
CLVS
2632
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
| $4.62M | ﹤0.01% |
+101,700
| New | +$4.95M |
2018 Q2
0 quarters
|
|
|
SRCLP
2633
DELISTED
Stericycle, Inc
SRCLP
| $4.62M | ﹤0.01% |
102,160
-16,961
| -14% | -$807K |
2015 Q3
11 quarters
|
|
2634
Star Group
SGU
$422M
| $4.61M | ﹤0.01% |
469,847
-50,945
| -10% | -$490K |
2018 Q1
1 quarter
|
|
2635
CALL
Occidental Petroleum
OXY
$57.9B
| $4.6M | ﹤0.01% |
55,000
| – | – |
2014 Q3
15 quarters
|
|
|
2636
PUT
Occidental Petroleum
OXY
$57.9B
| $4.6M | ﹤0.01% |
55,000
| – | – |
2016 Q4
6 quarters
|
|
2637
Wabtec
WAB
$48.6B
| $4.59M | ﹤0.01% |
46,611
-1,425
| -3% | -$133K |
2013 Q2
20 quarters
|
|
2638
Dr. Reddy's Laboratories
RDY
$10.2B
| $4.59M | ﹤0.01% |
713,445
+243,865
| +52% | +$1.54M |
2013 Q2
20 quarters
|
|
|
HMSY
2639
DELISTED
HMS Holdings Corp.
HMSY
| $4.58M | ﹤0.01% |
211,816
+77,225
| +57% | +$1.56M |
2014 Q4
14 quarters
|
|
|
DOC
2640
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $4.58M | ﹤0.01% |
287,257
+221,815
| +339% | +$3.35M |
2015 Q4
10 quarters
|
|
2641
PUT
Cheesecake Factory
CAKE
$5.38B
| $4.57M | ﹤0.01% |
+83,000
| New | +$4.39M |
2018 Q2
0 quarters
|
|
|
DO
2642
DELISTED
Diamond Offshore Drilling
DO
| $4.57M | ﹤0.01% |
219,052
+87,286
| +66% | +$1.63M |
2013 Q2
20 quarters
|
|
2643
CNA Financial
CNA
$12.5B
| $4.56M | ﹤0.01% |
99,842
+81,061
| +432% | +$3.92M |
2015 Q2
12 quarters
|
|
|
SUP
2644
DELISTED
Superior Industries International
SUP
| $4.56M | ﹤0.01% |
254,843
+171,767
| +207% | +$2.81M |
2015 Q4
10 quarters
|
|
2645
Silicon Laboratories
SLAB
$7.42B
| $4.55M | ﹤0.01% |
45,705
+76
| +0.2% | +$7.6K |
2015 Q4
10 quarters
|
|
2646
Medpace
MEDP
$16.7B
| $4.55M | ﹤0.01% |
105,771
+60,524
| +134% | +$2.44M |
2017 Q3
3 quarters
|
|
|
CLVS
2647
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
| $4.55M | ﹤0.01% |
100,000
+41,500
| +71% | +$2.02M |
2018 Q1
1 quarter
|
|
2648
CALL
iShares Silver Trust
SLV
$29.4B
| $4.54M | ﹤0.01% |
300,000
| – | – |
2016 Q3
7 quarters
|
|
2649
Mattel
MAT
$4.27B
| $4.54M | ﹤0.01% |
276,653
-6,606
| -2% | -$100K |
2013 Q2
20 quarters
|
|
|
CRC
2650
DELISTED
California Resources Corporation
CRC
| $4.54M | ﹤0.01% |
99,808
-49,165
| -33% | -$1.56M |
2014 Q4
14 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2018 Portfolio in Review
As of Q2 2018, JP Morgan Chase held 5,918 positions worth $486B, up 4.2% from $467B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2018 filing shows 539 new, 2,430 increased, 2,080 reduced and 346 closed positions. Its largest new stake was Evergy: 3,598,208 shares worth $202M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.58B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2018 buy was Evergy: 3,598,208 shares worth $202M.
- JP Morgan Chase added most to Salesforce in Q2 2018, an estimated $1.09B increase.
- JP Morgan Chase's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.58B.
- JP Morgan Chase fully exited Time Warner Inc in Q2 2018, selling an estimated $764M.
- JP Morgan Chase's ten largest holdings make up 17% of its $486B portfolio in Q2 2018.
- JP Morgan Chase opened 539 new positions and closed 346 in Q2 2018.
- JP Morgan Chase's portfolio value rose 4.2% quarter-over-quarter to $486B.
Based on JP Morgan Chase's 13F filing for Q2 2018, filed 14 Aug 2018.